Idiopathic CD4 lymphocytopenia leaves people vulnerable to infectious diseases, autoimmune diseases and cancers

Thursday, May 4, 2023 NIH Researchers Uncover New Details on Rare Immune Disease NIH scientists uncovered new details on idiopathic CD4 lymphocytopenia (ICL), a rare immune deficiency that leaves people vulnerable to infectious diseases, autoimmune diseases and certain types of cancer. ICL is a condition marked by too few CD4+ T cells—a type of white blood cell. There is no evidence that ICL is transmitted from person to person, and it has no known cause. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107